Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Singer

Showing results (191-200 of 313) with videos related to

Pageof 32
Sort By:
Diabetes Care|September 29, 2004
A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP)Richard W Grant, Enrico Cagliero, Christine M Sullivan, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
American Heart Journal|February 20, 2025
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trialJeffrey M Ashburner, Reinier W P Tack, Shaan Khurshid, et al.
Heart Rhythm|May 1, 2024
Automated interpretations of single-lead electrocardiograms predict incident atrial fibrillation: The VITAL-AF trialDaniel C Pipilas, Shaan Khurshid, Mostafa A Al-Alusi, et al.
Journal of the American Heart Association|December 24, 2017
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)Kevin L Thomas, Larry R Jackson, Peter Shrader, et al.
American Heart Journal|April 26, 2022
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitorDaniel E Singer, Steven J Atlas, Alan S Go, et al.
Trials|May 6, 2020
Correction to: Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trialNancy A Rigotti, Kristina Schnitzer, Esa M Davis, et al.
Trials|April 18, 2020
Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trialNancy A Rigotti, Kristina Schnitzer, Esa M Davis, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
Journal of the American Heart Association|December 29, 2023
Characteristics and Attitudes of Wearable Device Users and Nonusers in a Large Health Care SystemRachael A Venn, Shaan Khurshid, Mia Grayson, et al.
Pageof 32

Showing results (191-200 of 313) with videos related to

Sort By:
Pageof 32
Diabetes Care|September 29, 2004
A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP)Richard W Grant, Enrico Cagliero, Christine M Sullivan, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
American Heart Journal|February 20, 2025
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trialJeffrey M Ashburner, Reinier W P Tack, Shaan Khurshid, et al.
Heart Rhythm|May 1, 2024
Automated interpretations of single-lead electrocardiograms predict incident atrial fibrillation: The VITAL-AF trialDaniel C Pipilas, Shaan Khurshid, Mostafa A Al-Alusi, et al.
Journal of the American Heart Association|December 24, 2017
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)Kevin L Thomas, Larry R Jackson, Peter Shrader, et al.
American Heart Journal|April 26, 2022
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitorDaniel E Singer, Steven J Atlas, Alan S Go, et al.
Trials|May 6, 2020
Correction to: Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trialNancy A Rigotti, Kristina Schnitzer, Esa M Davis, et al.
Trials|April 18, 2020
Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trialNancy A Rigotti, Kristina Schnitzer, Esa M Davis, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
Journal of the American Heart Association|December 29, 2023
Characteristics and Attitudes of Wearable Device Users and Nonusers in a Large Health Care SystemRachael A Venn, Shaan Khurshid, Mia Grayson, et al.
Pageof 32